NCT06013423
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Blastic Plasmacytoid Dendritic Cell Neoplasm
Explore clinical trials studying Blastic Plasmacytoid Dendritic Cell Neoplasm. Study availability and eligibility vary by location and protocol.
16 public trials
4 recruiting studies
Blastic Plasmacytoid Dendritic Cell Neoplasm trial results
NCT03113643
- Conditions
- Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, +16 more
- Locations
-
- City of Hope Duarte, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
NCT04216524
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hematologic Neoplasms, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT05362773
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Chronic Disease, +37 more
- Locations
-
- Colorado Blood Cancer Network Denver, Colorado, United States
- University of Maryland, Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- START - Midwest Grand Rapids, Michigan, United States
Active, not recruiting
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
NCT02159495
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
- Locations
-
- Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- UCLA Los Angeles, California, United States
- Stanford Stanford, California, United States
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03485547
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hematologic Neoplasms, +10 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT02730312
- Conditions
- Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blast Crisis, +39 more
- Locations
-
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States